AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Market Snapshot
Clorox (CLX) is trading lower by -2.19%, with technical indicators signaling a weak trend and analysts showing a divided stance. Investors should proceed with caution.
News Highlights
Recent news affecting the household and consumer goods sector includes:
- New U.S. tariffs on EU and U.K. imports (effective Aug. 1) could raise the cost of European-made spirits and wines. While isn’t directly involved, the broader economic impact could affect consumer spending patterns.
- Ball Corporation (BALL) announced a quarterly dividend and appointed a new CIO, which could indicate stability in the sector. However, Clorox’s performance remains uncorrelated with these developments.
- Colgate-Palmolive (CL) and Church & Dwight (CHD) reported mixed Q2 earnings, with Colgate slightly outperforming while Church & Dwight underperformed. These results highlight the competitive dynamics in the household goods space, where Clorox operates.
Analyst Views & Fundamentals
Clorox is currently showing a simple average analyst rating of 2.80 and a performance-weighted rating of 3.98. Analysts are divided in their views, with one "Sell" and four "Neutral" ratings in the last 20 days.
Despite the mixed analyst sentiment, Clorox's fundamental score is strong at 8.16, reflecting solid operational and financial metrics:
- Price-to-Sales (PS) ratio: 10.76 (score: 3/10) – Indicates a relatively high valuation based on sales.
- Operating Cycle: 92.00 days (score: 1/10) – Suggests efficient inventory and accounts receivable management.
- Inventory Turnover Days: 58.12 days (score: 1/10) – Reflects quick inventory turnover, a positive operational sign.
- Cost of Sales Ratio: 55.19% (score: 3/10) – Indicates a moderate cost structure.
- Net Cash Flow from Operating Activities (YoY growth rate): 131.79% (score: 4/10) – Shows strong growth in operating cash flow.
While fundamentals are robust, the disconnect between analyst sentiment and the stock's falling price suggests market uncertainty or caution.
Money-Flow Trends
Clorox is seeing positive money-flow patterns, with overall inflow ratio at 50.80%, indicating that both retail and institutional investors are showing net inflows. The breakdown by investor type is:
- Small investors inflow ratio: 51.44%
- Medium investors inflow ratio: 50.83%
- Large investors inflow ratio: 50.81%
- Extra-large investors inflow ratio: 50.75%
This suggests strong broad-based interest, with no clear divergence between retail and big-money flows. The fund-flow score of 7.95 is a positive sign for near-term momentum.
Key Technical Signals
Clorox’s technical outlook is mixed to weak, with the technical score at 4.5. Here's what the internal diagnostic scores and recent signals suggest:
- Williams %R Oversold (score: 2.5/10) – A weak signal indicating the stock is near oversold territory, but it’s not strong enough to trigger a reversal.
- Williams %R Overbought (score: 6.5/10) – A moderate positive signal, but it’s not enough to outweigh the bearish indicator.
Recent chart patterns include:
- July 28 – A "Marubozu Black" candle, signaling strong bearish momentum.
- July 30 – Williams %R entered oversold territory, suggesting a potential bounce, but with caution needed.
Overall, the key technical insight is that the stock is in a weak and indecisive phase, with 1 bearish indicator, 0 bullish indicators, and 1 neutral indicator in the recent 5-day period.
Conclusion
Clorox is in a mixed technical and sentiment phase, with strong fundamentals but weak technical signals and divided analyst views. Investors should wait for clearer directional momentum before committing to new positions. With positive money flows and solid operational metrics, a pull-back could offer an opportunity for cautious buyers. Watch for earnings or macro updates that could clarify the near-term path.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.

Dec.31 2025

Dec.31 2025

Dec.31 2025

Dec.31 2025

Dec.31 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet